X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (28) 28
female (24) 24
male (23) 23
index medicus (22) 22
adult (21) 21
middle aged (18) 18
rheumatology (18) 18
systemic sclerosis (18) 18
scleroderma (13) 13
immunology (12) 12
iran (11) 11
fibrosis (10) 10
scleroderma, systemic - genetics (10) 10
case-control studies (9) 9
rheumatoid arthritis (9) 9
systemic scleroderma (9) 9
aged (8) 8
pathogenesis (8) 8
prevalence (8) 8
analysis (7) 7
apoptosis (7) 7
arthritis (7) 7
c-abl (7) 7
gene expression (7) 7
iran - epidemiology (7) 7
adolescent (6) 6
fibroblast (6) 6
systemic lupus erythematosus (6) 6
young adult (6) 6
allergy (5) 5
animals (5) 5
ankylosing spondylitis (5) 5
care and treatment (5) 5
classification (5) 5
dermatology (5) 5
disease (5) 5
epidemiology (5) 5
genes (5) 5
imod (5) 5
oxidative stress (5) 5
rna (5) 5
scleroderma, systemic - diagnosis (5) 5
association (4) 4
cross-sectional studies (4) 4
dermis - pathology (4) 4
expression (4) 4
m2000 (4) 4
mannuronic acid (4) 4
medical research (4) 4
medicine & public health (4) 4
medicine, experimental (4) 4
patients (4) 4
quality of life (4) 4
revised criteria (4) 4
rheumatoid factor (4) 4
severity of illness index (4) 4
tgf-beta (4) 4
therapy (4) 4
age (3) 3
american-college (3) 3
apoptosis - genetics (3) 3
arthritis, rheumatoid - drug therapy (3) 3
bcl-2-associated x protein - genetics (3) 3
behcet's disease (3) 3
biomarkers (3) 3
collagen (3) 3
dermal fibroblasts (3) 3
disease-activity (3) 3
dna methylation (3) 3
down-regulation (3) 3
efficacy (3) 3
fibroblasts (3) 3
fibroblasts - metabolism (3) 3
gene expression regulation - drug effects (3) 3
genetic research (3) 3
health surveys (3) 3
inflammatory bowel disease (3) 3
mechanisms (3) 3
micrornas - genetics (3) 3
odds ratio (3) 3
original (3) 3
pharmacology & pharmacy (3) 3
polymerase chain reaction (3) 3
population (3) 3
proto-oncogene proteins c-bcl-2 - genetics (3) 3
pulmonary-fibrosis (3) 3
rheumatic diseases (3) 3
risk factors (3) 3
rna, messenger - genetics (3) 3
safety (3) 3
scleroderma, systemic - metabolism (3) 3
setarud (3) 3
skin (3) 3
studies (3) 3
time factors (3) 3
toxicology (3) 3
treatment outcome (3) 3
tumor necrosis factor-alpha - metabolism (3) 3
acids (2) 2
activation (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Molecular and Cellular Biochemistry, ISSN 0300-8177, 07/2015, Volume 405, Issue 1-2, p. 169
It is generally accepted that the apoptosis of myofibroblasts is a crucial event in the normal wound healing. Delay in myofibroblasts apoptosis results in... 
Systemic scleroderma | RNA | Analysis | Scleroderma (Disease) | Bone morphogenetic proteins | Transforming growth factors | Apoptosis | Multiple sclerosis | Inhibitor drugs | Cytokines
Journal Article
Human Immunology, ISSN 0198-8859, 03/2018, Volume 79, Issue 3, pp. 178 - 187
The pathogenesis of many diseases is influenced by environmental factors which can affect human genome and be inherited from generation to generation. Adverse... 
Epigenetics | SSc | Vascular injury | Immune abnormality | Fibrosis | TGF-BETA | DNA METHYLATION | BONE MORPHOGENETIC PROTEIN | DOWN-REGULATION | IMMUNOLOGY | MESENCHYMAL TRANSITION | I COLLAGEN EXPRESSION | DERMAL FIBROBLASTS | EXTRACELLULAR-MATRIX | GROWTH-FACTOR | T-CELLS
Journal Article
Journal Article
Rheumatology International, ISSN 0172-8172, 3/2018, Volume 38, Issue 3, pp. 489 - 498
Systemic sclerosis (SSc), an autoimmune disease of connective tissue, is characterized by inflammation, fibrosis, and vessel endothelial damage. Products of... 
Medicine & Public Health | SELL | CpG site | Systemic sclerosis | Rheumatology | ITGB2 | DNA methylation | HYPERMETHYLATION | C-ABL | EPIGENETIC MODIFICATIONS | DOWN-REGULATION | ANKYLOSING-SPONDYLITIS | RHEUMATOLOGY | PATHOGENESIS | POLYMORPHISMS | INHIBITION | IRANIAN PATIENTS | Gene expression
Journal Article
Modern rheumatology, ISSN 1439-7595, 08/2019, pp. 1 - 8
: Survivin is an important anti-apoptotic protein and is involved in increasing auto-reactivity during the autoimmune diseases like Systemic sclerosis (SSc). :... 
Journal Article
International Journal of Rheumatic Diseases, ISSN 1756-1841, 10/2017, Volume 20, Issue 10, pp. 1551 - 1561
Objective: The aim of the current study was to evaluate if methylation status of CpG sites of interferon regulatory factor 7 (IRF7) promoter in peripheral... 
systemic sclerosis | CpG island | DNA | methylation | interferon regulatory factor 7 | DNA methylation | VIRUS LATENT MEMBRANE-PROTEIN-1 | CD4+ T-CELLS | C-ABL | EPIGENETIC MODIFICATIONS | RHEUMATOLOGY | OVEREXPRESSION | SCLERODERMA | I INTERFERONS | DISEASE | DERMAL FIBROBLASTS | Scleroderma, Systemic - blood | Epigenesis, Genetic | Humans | Middle Aged | Male | Interferon Regulatory Factor-7 - genetics | Case-Control Studies | Scleroderma, Diffuse - genetics | Scleroderma, Diffuse - blood | Scleroderma, Limited - blood | Scleroderma, Systemic - diagnosis | DNA Methylation | Scleroderma, Limited - genetics | Scleroderma, Limited - diagnosis | Adult | Female | Interferon Regulatory Factor-7 - blood | Promoter Regions, Genetic | Genetic Association Studies | RNA, Messenger - genetics | Scleroderma, Systemic - genetics | Scleroderma, Diffuse - diagnosis | Leukocytes, Mononuclear - chemistry | RNA, Messenger - blood | CpG Islands | Sulfites | Care and treatment | RNA | Systemic scleroderma | Analysis | Genes | Scleroderma (Disease) | Genetic research | Interferon | Methylation | Gene expression | Biological response modifiers | Bisulfite | Nucleotide sequence | Pathogenesis | Leukocytes (mononuclear) | Polymerase chain reaction | Interferon regulatory factor 7 | Systemic sclerosis | Peripheral blood mononuclear cells | Deoxyribonucleic acid--DNA | Interferon regulatory factor | CpG islands
Journal Article